Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.625
-0.025 (-1.52%)
Jul 30, 2026, 1:22 PM EDT - Market open
Neumora Therapeutics Employees
Neumora Therapeutics had 92 employees as of March 31, 2026. The number of employees decreased by 4 or -4.17% since the number was last reported on December 31, 2025.
Employees
92
Change
-4
Growth
-4.17%
Revenue / Employee
n/a
Profits / Employee
-$2,417,326
Market Cap
301.09M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 92 | -4 | -4.17% |
| Dec 31, 2025 | 96 | -14 | -12.73% |
| Dec 31, 2024 | 110 | -14 | -11.29% |
| Dec 31, 2023 | 124 | 30 | 31.91% |
| Dec 31, 2022 | 94 | 6 | 6.82% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Abeona Therapeutics | 226 |
| Rocket Pharmaceuticals | 202 |
| Lyell Immunopharma | 161 |
| Foghorn Therapeutics | 106 |
| Zentalis Pharmaceuticals | 106 |
| OmniAb | 89 |
| Scribe Therapeutics | 89 |
NMRA News
- 3 days ago - Neumora Therapeutics reports pre-clinical toxicology results from NMRA-215 study - TheFly
- 3 days ago - Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026 - GlobeNewsWire
- 17 days ago - Neumora Therapeutics price target lowered to $5 from $7 at RBC Capital - TheFly
- 4 weeks ago - Neumora Therapeutics Slides: Corporate presentation - Filings
- 6 weeks ago - Neumora Therapeutics price target lowered to $4 from $6 at Mizuho - TheFly
- 6 weeks ago - Neumora Therapeutics Slides: Investor presentation - Filings
- 6 weeks ago - Neumora Therapeutics price target lowered to $5 from $8 at Needham - TheFly
- 6 weeks ago - Neumora Therapeutics price target lowered to $7 from $18 at H.C. Wainwright - TheFly